Just two days after Novo Nordisk launched Wegovy (semaglutide 2.4 mg) in India, Eli Lilly received regulatory approval for ...

MASLD, a liver disease linked to obesity and poor lifestyle, is rising among children. Often symptomless early on, it can ...

If Dr. Corkey is right, this discovery could change the way we think about weight gain and obesity. It suggests that just ...

Mr Streeting told LBC radio: “Weight-loss jabs are the talk of the House of Commons, half my colleagues are on them and are ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Amgen Inc. (NASDAQ: AMGN) is one of the. On June 23, the company announced full results from Part 1 of the Phase 2 study of ...

A clinical trial for semaglutide, the active ingredient in Ozempic, found that it improved blood sugar control in people with ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Obesity is associated with financial hardship and food insecurity, according to a research letter published online June 24 in ...

A new study compares body mass index (BMI) with body fat percentage and finds the latter is far more reliable in predicting ...

About 69,000 new cases and nearly 14,000 deaths are expected this year, according to the American Cancer Society.